US2005202039A1PendingUtilityA1

Renibacterium salmoninarum vaccine

Priority: Jan 30, 1997Filed: May 10, 2005Published: Sep 15, 2005
Est. expiryJan 30, 2017(expired)· nominal 20-yr term from priority
C12R 2001/06A61K 2039/552A61K 2039/522C07K 14/195C12N 1/205A61K 39/05
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides an immune stimulating agent or vaccine directed to Renibacterium salmoninarium comprising a live non-virulent culture of an Arthrobacter strain based on derived from or substantially homologous with strain RSxII as deposited as ATCC 55921. The culture may be presented in lyophilised form with a sterile diluent.

Claims

exact text as granted — not AI-modified
1 - 23 . (canceled)  
     
     
         24 . A method of inducing an immune response in fish comprising 
 administering an effective immunizing dose of an  Arthrobacter  species to said fish.    
     
     
         25 . The method of  claim 24  further comprising administering an adjuvant to said fish.  
     
     
         26 . The method of  claim 24  wherein said  Arthrobacter  species has a partial 16s DNA sequence that is similar to the polynucleotide sequence of SEQ ID NO: 1.  
     
     
         27 . The method of  claim 24  wherein said  Arthrobacter  species has one or more of the following characteristics selected from the group consisting of (a) positive gram stain, easily discolored; (b) nonmotile; (c) in log phase growth, the cells are between approximately 0.8 and 1.2 μm by between approximately 1.0 and 8.0 μm, are often V-shaped with clubbed end; (d) as the organism approaches stationary phase, the rods segment into small cocci of approximately 0.6 to 1.0 μm in diameter; (e) catalase reaction positive; (f) oxidase reaction positive; (g) are positive to enzymatic reactions with alkaline phosphates, butyrate esterase, caprylate esterase, leucine arylamidase, trypsin, acid phosphatase, β-glucuronidase, α-glucosidase, and α-mannosidase; (h) are negative to enzymatic reactions with myristate lipase, cystine arylamidase, chymostrypsin, phosphoamidase, α-galactosidase, β-glucosidase, N-acetyl-β-glucosamidase, and α-fucosidase; and (i) are weakly positive to enzymatic reactions with valine arylamidase and β-galactosidase.  
     
     
         28 . The method of  claim 24  wherein said  Arthrobacter  species has similar physical characteristics as  Arthrobacter  strain RSxII (ATCC Deposit Accession No ATCC 55921).  
     
     
         29 . The method of  claim 24  wherein said  Arthrobacter  species is  Arthrobacter  strain RSxII (ATCC Deposit Accession No ATCC 55921).

Join the waitlist — get patent alerts

Track US2005202039A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.